The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of an artificial intelligence model to predict Ki67 from H&E-stained whole slides images in breast cancer.
 
Daniel Kates-Harbeck
No Relationships to Disclose
 
Martin Filipits
Honoraria - AstraZeneca; Bio-Rad; Boehringer Ingelheim; Lilly; Merck; Novartis
 
Hans Kreipe
Honoraria - AstraZeneca; Daiichi Sankyo; Genomic Health; Lilly; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Genomic Health; Lilly; Roche Pharma AG
 
Dominik Hlauschek
Research Funding - Amgen (Inst); Amgen (Inst); Artera (Inst); AstraZeneca (Inst); Ataraxis (Inst); Berlin Chemie AG (Inst); Bristol Myers Squibb (Inst); Cepheid (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Natera (Inst); Novartis (Inst); OncoMark (Inst); Pfizer (Inst); Roche (Inst); Sandoz (Inst)
 
Matthias Christgen
No Relationships to Disclose
 
Gabriel Rinnerthaler
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Roche; Seagen; Stemline Therapeutics
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Stemline Therapeutics
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Gilead Sciences; Roche
 
Oleg Gluz
Honoraria - AstraZeneca; Celgene; Genomic Health/Exact Sciences; NanoString Technologies; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Celgene; Genomic Health/Exact Sciences; NanoString Technologies; Novartis; Pfizer; Roche
 
Simon Gampenrieder
No Relationships to Disclose
 
Sven Mahner
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Karin Haider
No Relationships to Disclose
 
Wolfgang Hulla
No Relationships to Disclose
 
Ronald Kates
No Relationships to Disclose
 
Jingbin Zhang
Employment - Artera
Stock and Other Ownership Interests - Artera
 
Alexander Piehler
No Relationships to Disclose
 
Hans Pinckaers
Employment - Atera
Stock and Other Ownership Interests - Atera
 
Gijs Smit
Employment - Atera
Stock and Other Ownership Interests - Atera
 
Jacqueline Griffin
Employment - Artera
Stock and Other Ownership Interests - Artera
 
Nadia Harbeck
Stock and Other Ownership Interests - West German Study Group
Honoraria - AstraZeneca; Daiichi-Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; Viatris; Zuelligpharma
Consulting or Advisory Role - Gilead Sciences; Roche/Genentech; Seagen; West German Study Group (I)
Speakers' Bureau - EPG Communication; Medscape; Springer Healthcare
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Roche/Genentech (Inst)
 
Michael Gnant
Employment - Sandoz (I)
Honoraria - Amgen; AstraZeneca; Daiichi Sankyo Europe GmbH; EPG Health; Lilly; Menarini; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Bayer; Daiichi-Sankyo; Lilly; Menarini; MSD Oncology; Novartis; Veracyte
Expert Testimony - Lilly; Veracyte
Travel, Accommodations, Expenses - Lilly; Stemline Therapeutics
Other Relationship - ABCSG GmbH; ABCSG Research Services GmbH